IO-202 - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image of premium spirits bottles and market screens illustrating the Pernod Ricard SA and Brown-Forman Corporation merger talks that could reshape the global spirits industry.

Pernod Ricard and Brown-Forman confirm merger talks that could reshape the global spirits industry

Judge blocks Pentagon from blacklisting Anthropic: ‘Classic First Amendment retaliation’

Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform

Representative image of a laboratory skin research setting illustrating the kind of translational science behind Rubedo Life Sciences’ RLS-1496 Phase 1 dermatology results in psoriasis, atopic dermatitis, and skin aging.

Aging biotech just got a real skin test and Rubedo Life Sciences may have passed the first one

FDA Grants Orphan Drug Designation to Immune-Onc Therapeutics IO-202 for CMML Treatment

Read More

2 minute read

Pharma Industry News

Immune-Onc Therapeutics gets FDA orphan drug status for IO-202 in CMML

Immune-Onc Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative therapies in immunology and oncology,…

byPallavi Madhiraju

February 22, 2024

web analytics